Silo Pharma, Inc. (SILO)
Nasdaq: SILO · Pharmaceutical Preparations · Sarasota, FL · filing with the SEC since 2011
Who owns Silo Pharma, Inc.
As filed with the SECHolders of 5% or more
2
Mitchell P. Kopin holds 9.99% of Common stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
1
report now, of 7 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Mitchell P. Kopin
SCHEDULE 13G/A · filed Aug 13, 2026 · Common stock, par value $0.0001 per share · 9.99% in Feb 13, 2026
AdvisorShares Trust
SCHEDULE 13G · filed Jul 8, 2026 · Common Stock, $0.0001 par value per share
Anson Funds Management LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 7.2% in Nov 14, 2025
Renaissance Technologies LLC
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.06% in Nov 13, 2024
SEG Opportunity Fund, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 7.1% in Oct 3, 2025
What SILO reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 25, 2024.
Insider tradesForm 4
0sales
6purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 7 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer | 0 | $0 | 0 | 6 | $0 |